Birmingham, West Midlands -- (SBWIRE) -- 01/28/2014 -- Value Penny Stocks issues special report on Kandi Technologies Group Inc (NASDAQ:KNDI), Hudson City Bancorp, Inc. (NASDAQ:HCBK), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Northwest Biotherapeutics, Inc (NASDAQ:NWBO).
Kandi Technologies Group Inc (NASDAQ:KNDI) ended its recent business day with the loss of -6.14% and closed at the price of $11.61 after opening at $12.45. The stock traded during its last trading session with the total volume of 2,862,877 shares, as compared to its average volume of 3.05 million shares. Kandi Technologies Group, Inc., through its subsidiaries, engages in the design, development, manufacture, and commercialization of various vehicles. It offers electrical vehicles, all-terrain vehicles, go-karts, and specialized automobiles; and utility vehicles, three-wheeled motorcycle, refitted cars, super-mini-cars, and various auto generators.
Has KNDI Found The Bottom and Ready To Move Up? Find Out Here
Hudson City Bancorp, Inc. (NASDAQ:HCBK) remained among the day decliners and traded with volume of 2,848,185 shares in the last session, as compared to average volume of 4.94 million shares. In comparison with 52 week range of $7.67 - $9.79, it faced lowest price of $8.99 during the last trading session whereas its day highest price was $9.13. The company’s total market capitalization is $4.76 billion, along with 528.42 million shares outstanding. Hudson City Bancorp, Inc. operates as the holding company of Hudson City Savings Bank that provides various banking products and services in the United States.
Has HCBK Found The Bottom And Ready To Gain Momentum? Find Out Here
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) showed 2,746,658 shares in volume during the last trading session, while the average trading volume remained 2.37 million shares. The stock kicked off its trading session at $3.66 and closed at $3.44 after declining -6.27%. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on the development of antivirals for the treatment of chronic hepatitis C viral (HCV) infection.
Why Should Investors Buy ACHN After the Recent Fall? Just Go Here and Find Out
Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock traded during its last trading session with the total traded volume of 2,732,504 shares versus its average volume of 805,735.00 shares. The company opened its trade at the price of $5.10 and its closing price was $5.00 after gaining 3.31% for the day. Northwest Biotherapeutics, Inc., a development stage biotechnology company, engages in discovering, developing, and commercializing immunotherapy products to treat cancers in the United States. Its DCVax uses activated dendritic cells to mobilize a patient?s own immune system to attack their cancer.
Why Should Investors Buy NWBO After The Recent Gain? Just Go Here and Find Out NWBO
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)